De Bie, C I <br/><br/>
The duration of effect of infliximab maintenance treatment in paediatric Crohn's disease is limited.  [electronic resource] 

 -  Alimentary pharmacology & therapeutics  Jan 2011 
 - 243-50 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1365-2036 
<br/><br/><label>Standard No.: </label>10.1111/j.1365-2036.2010.04507.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Antibodies, Monoclonal--therapeutic use<br/>Child<br/>Crohn Disease--drug therapy<br/>Female<br/>Follow-Up Studies<br/>Gastrointestinal Agents--therapeutic use<br/>Humans<br/>Infliximab<br/>Male<br/>Netherlands<br/>Time Factors<br/>Treatment Outcome